Amyotrophic Lateral Sclerosis (ALS) Diagnosis and Management
Definition and Classification
- The American College of Radiology states that ALS is a relentlessly progressive neurodegenerative condition characterized by degeneration of both upper and lower motor neurons in the brain and spinal cord, leading to progressive muscle weakness, paralysis, and typically death within 3-5 years of symptom onset 1, 2
- ALS is the most common motor neuron disease, representing approximately 85% of all motor neuron disease cases, according to Praxis Medical Insights 3, 2
Pathophysiology
- ALS involves progressive degeneration of both upper motor neurons and lower motor neurons along the corticospinal tracts, as stated by the Journal of the American College of Radiology and Praxis Medical Insights 1, 3
- The etiology is multifactorial, involving increased oxidative stress, glutamate toxicity, mitochondrial dysfunction, inflammation, and apoptosis, according to Praxis Medical Insights 3
Clinical Presentation
- Classical ALS presents with mixed upper and lower motor neuron signs, including upper motor neuron signs such as hypertonicity and hyperreflexia, and lower motor neuron signs such as muscle fasciculations, weakness, and atrophy, as described by the Journal of the American College of Radiology 1
- Approximately 80% of patients with bulbar-onset ALS develop dysarthria and dysphagia, according to Praxis Medical Insights 3, 4
Diagnosis
- Key diagnostic tests include MRI of the brain and spine, which can show abnormal T2/FLAIR signal in the corticospinal tracts and abnormal T2 signal in the anterior horns, as stated by the Journal of the American College of Radiology and Praxis Medical Insights 1, 3
Prognosis
- Mean survival of typical ALS patients is 3-5 years after symptom onset, according to Praxis Medical Insights 3, 2
- Only 5-10% of patients live longer than 10 years, as stated by Praxis Medical Insights 3, 2
- Respiratory failure due to respiratory muscle weakness is the most common cause of death, according to the Journal of Neurology, Neurosurgery and Psychiatry 5
Treatment
- Nutritional support for dysphagia and weight loss is essential, as stated by Praxis Medical Insights 3
- Palliative care should be integrated from the time of diagnosis, with emphasis on patient autonomy, dignity, and quality of life, according to the Journal of Neurology, Neurosurgery and Psychiatry 5, 6
Important Considerations
- Early referral to palliative services is recommended to establish relationships with staff and address end-of-life issues before communication becomes limited, as stated by the Journal of Neurology, Neurosurgery and Psychiatry 5, 6
- Support for caregivers is crucial, as they often experience significant burden, according to the Journal of Neurology, Neurosurgery and Psychiatry 5
Management of Amyotrophic Lateral Sclerosis (ALS)
Rationale for Palliative Care Approach
- The European Federation of Neurological Sciences taskforce recommends adopting a palliative care approach from the time of diagnosis, as ALS is a relentlessly progressive neurodegenerative disease with a mean survival of 3-5 years after symptom onset 7
- Early referral to palliative services is essential to establish relationships with staff and address end-of-life issues before communication becomes limited 8
- There is considerable evidence that multidisciplinary care improves both survival and quality of life in ALS, according to the European Federation of Neurological Sciences 7
Components of Multidisciplinary Palliative Care
- Advance care planning should be initiated early, including discussions about advance directives, as considered useful in 78% of European centers, although only 30% of patients actually complete advance directives 9
- Address preferences regarding ventilatory support, feeding tubes, and end-of-life care, as part of advance care planning 9
- Implement structured caregiver support including counseling, support groups, and crisis management systems, as behavioral deficits in ALS have significant negative impact on caregivers' quality of life 9
Special Considerations
- Up to 40% of patients with ALS have evidence of cognitive impairment, which may affect treatment decisions and compliance, according to the European Federation of Neurological Sciences taskforce 9
- Despite international consensus on multidisciplinary approaches, integration of palliative care in ALS management varies considerably across healthcare systems 10
Pitfalls to Avoid
- Late referral to palliative services is common and negatively impacts quality of life, as stated by the European Federation of Neurological Sciences taskforce 7
- Access to assistive equipment might sometimes be limited once the patient formally receives palliative care, highlighting the need for early integration of palliative care into larger multidisciplinary care 9
Axonal Degeneration in ALS
Pathophysiology
- The American College of Radiology suggests that ALS is fundamentally a disease of axonal degeneration affecting motor neurons, not a demyelinating disease, with primary pathological process being progressive degeneration and death of the motor neurons themselves and their axons 11
Imaging Findings
- MRI findings in ALS show abnormal T2/FLAIR signal anywhere within the corticospinal tracts, which corresponds to underlying demyelination, axonal degeneration, AND gliosis seen on histopathology, with any demyelination seen being secondary to the primary axonal degeneration 11
- The American College of Radiology notes that spinal imaging may show abnormal T2 signal in the anterior horns with a "snake eyes" appearance, reflecting lower motor neuron disease 11
Critical Distinction from True Demyelinating Diseases
- Multiple sclerosis is the classic demyelinating disease, characterized by widespread focal degradation of the myelin sheath as the PRIMARY pathological process, with demyelination being the initial insult, and axonal injury being variable and secondary 12
Management of Amyotrophic Lateral Sclerosis (ALS) Nutrition
Dysphagia Management
- Modification of food texture is often required to compensate for a poor oral preparation phase and ease oral and pharyngeal transport while avoiding episodes of choking, as recommended by the European Society for Clinical Nutrition and Metabolism, with the goal of preventing aspiration and improving nutritional intake 13, 14
- The chin-tuck posture is a valuable protection mechanism for the airways, offering a useful technique in the majority of cases to prevent penetration into the larynx, according to the American Academy of Nutrition and Dietetics 13, 14
- Head rotation is indicated in the case of hypertonicity, incomplete release or premature UES closure, as suggested by the European Society for Clinical Nutrition and Metabolism, to improve swallowing safety and efficiency 13, 14
- Hyperextended head posture is indicated in the absence of lingual pump only if safe transit is ensured, as recommended by the American Academy of Nutrition and Dietetics, to reduce the risk of aspiration 13, 14
- Throat clearing every three to four swallowing acts can prevent possible postswallowing inhalation in cases of penetration without aspiration into the laryngeal inlet, according to the European Society for Clinical Nutrition and Metabolism 13, 14
- Both the oral as well as the pharyngeal stage of swallowing may be compromised in ALS patients, and aspiration can be present even without clinical aspiration signs or subjective complaints, highlighting the need for careful assessment and management, as emphasized by the American Academy of Neurology 13, 14
Nutritional Supplementation
- Patients who experience appreciable levels of fatigue should be advised to eat their food as several small meals a day, with dietetic counseling focusing on meal enrichment by use of high-calorie foods, as recommended by the European Society for Clinical Nutrition and Metabolism 13
- Nutritional supplementation is recommended for ALS patients who do not cover their nutritional requirements with an enriched diet, though there is insufficient data to affirm that oral nutritional supplementation can improve survival, according to the American Academy of Nutrition and Dietetics 13, 14
- In case of constipation caused by abdominal weakness, dietary fiber can be added to the diet, as suggested by the European Society for Clinical Nutrition and Metabolism, to promote regular bowel movements and prevent constipation 13
Management of Sialorrhea
- Anti-muscarinic therapy or botulinum toxin A can be used to manage sialorrhea, though no evidence has been found to link the treatment of saliva problems with the improvement of dysphagia, as noted by the American Academy of Neurology 13, 14
Management of Amyotrophic Lateral Sclerosis (ALS) with Multidisciplinary Care
Respiratory Management
- Non-invasive ventilation (NIV) may be reduced in patients with cognitive impairment; assess cognitive function before recommending, as NIV compliance is crucial for improving quality of life and survival, according to the Journal of Neurology, Neurosurgery and Psychiatry 15
- Invasive mechanical ventilation decisions require careful advance planning, as only 4-9% of patients choose this option, with wide cultural variation, as reported in the Journal of Neurology, Neurosurgery and Psychiatry 15
Nutritional Support
- Gastrostomy placement rates vary significantly by country, with a mean feeding duration of 11-18 months, highlighting the need for individualized nutritional support, as noted in the Journal of Neurology, Neurosurgery and Psychiatry 15
Cognitive and Behavioral Assessment
- Screen all patients for cognitive impairment, as up to 40% have evidence of cognitive dysfunction that significantly impacts treatment decisions and prognosis, according to the Journal of Neurology, Neurosurgery and Psychiatry 15
- Cognitive impairment reduces likelihood of choosing long-term mechanical ventilation and decreases NIV compliance, emphasizing the importance of early cognitive assessment, as reported in the Journal of Neurology, Neurosurgery and Psychiatry 15
Advance Care Planning
- Initiate advance directive discussions early in the disease course, ideally at diagnosis, before communication becomes limited, as recommended by the Journal of Neurology, Neurosurgery and Psychiatry 16
Caregiver Support
- Implement structured caregiver support from diagnosis, as caregiver burden is substantial and worsens with behavioral deficits in patients, highlighting the need for comprehensive caregiver support, as noted in the Journal of Neurology, Neurosurgery and Psychiatry 15
Coordination of Care Across Disease Phases
- The Dutch model provides a clear framework for care coordination, with the neurologist serving as care coordinator in the diagnostic phase, as reported in the Journal of Neurology, Neurosurgery and Psychiatry 15
Critical Pitfalls to Avoid
- Late referral to palliative services is the most common and harmful error, negatively impacting quality of life for both patients and caregivers, emphasizing the importance of early palliative care integration, as noted in the Journal of Neurology, Neurosurgery and Psychiatry 16
Clinical Presentation and Management of Amyotrophic Lateral Sclerosis (ALS)
Diagnostic Features
- The American College of Radiology recommends MRI brain and spine without contrast to exclude structural lesions that can mimic ALS, and to look for abnormal T2/FLAIR signal in corticospinal tracts and "snake eyes" appearance in anterior horns, with a strength of evidence based on clinical expertise 17
- Muscle atrophy and fasciculations reflecting lower motor neuron degeneration are common features of ALS, according to the American College of Radiology 17
- Sialorrhea due to impaired swallowing of saliva is a symptom of bulbar-onset ALS, as reported in Clinical Nutrition 18
- Nasal regurgitation from soft palate weakness is another symptom of bulbar-onset ALS, as reported in Clinical Nutrition 18
Nutritional Management
- The Clinical Nutrition journal recommends assessing nutritional status through BMI and weight, with a target weight gain if BMI <25 kg/m², and weight stabilization if BMI 25-35 kg/m², with a strength of evidence based on clinical trials 18
ALS Diagnostic and Nutritional Guidelines (Evidence‑Based)
Dysphagia Assessment
Nutritional Assessment and Prognosis
Energy Requirements
Enteral Nutrition Timing
Body Composition and Survival
Dysphagia Screening and Cognitive Impairment in ALS
Dysphagia Assessment
Cognitive Impairment Impact
Terazosin: Approved Indications and Safety Profile
Approved Indications
- Terazosin is an α‑1 adrenergic blocker that is approved only for the treatment of benign prostatic hyperplasia (BPH) and hypertension, according to drug‑label information published in The Journal of Urology (2003)【24, 25】.
Safety Concerns Relevant to ALS Patients
- The most common adverse effects of terazosin are orthostatic hypotension and dizziness; these can increase the risk of falls in individuals who already have progressive weakness and mobility impairment【24, 25】.
- Terazosin may cause asthenia (tiredness), which would exacerbate the fatigue commonly experienced by patients with neurodegenerative motor disorders【24, 25】.